We are pioneering novel therapeutic approaches to elongate telomeres and combat age-related diseases at the cellular level.
Founded by researchers from Harvard Medical School
To develop groundbreaking telomere-based therapeutics that address the fundamental mechanisms of aging and age-related disease.
Targeting telomere biology to address aging at its most fundamental level—the chromosome.
Leveraging cutting-edge research in telomerase biology and cellular senescence to develop novel therapeutics.
Creating treatments for age-related diseases by restoring and maintaining telomere length and function.
Telomeres are protective caps at the ends of chromosomes that naturally shorten with each cell division. When telomeres become critically short, cells enter senescence or undergo apoptosis, contributing to tissue dysfunction and age-related diseases.
Our approach focuses on developing safe and effective methods to elongate telomeres in target tissues, potentially reversing cellular aging and restoring tissue function. By addressing this fundamental mechanism of aging, we aim to develop therapeutics for multiple age-related conditions.
We are building on decades of telomere research to translate basic science discoveries into clinical applications that could transform how we treat aging and age-related disease.
A comprehensive strategy for developing telomere therapeutics
Identifying disease indications where telomere elongation can provide maximum therapeutic benefit with optimal safety profiles.
Creating proprietary technologies for controlled telomere elongation in specific cell types and tissues.
Establishing clear pathways from preclinical validation to clinical trials and eventual patient treatment.
We are seeking strategic partners, investors, and collaborators who share our vision of transforming the treatment of age-related diseases.
[email protected]